248 related articles for article (PubMed ID: 28938676)
1. Risk factors for mortality from pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis.
Liu Y; Su L; Jiang SJ; Qu H
Oncotarget; 2017 Aug; 8(35):59729-59739. PubMed ID: 28938676
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors of Mortality From
Wang Y; Zhou X; Saimi M; Huang X; Sun T; Fan G; Zhan Q
Front Public Health; 2021; 9():680108. PubMed ID: 34222179
[No Abstract] [Full Text] [Related]
3. Pneumocystis jirovecii pneumonia mortality risk associated with preceding long-term steroid use for the underlying disease: A multicenter, retrospective cohort study.
Miyake K; Senoo S; Shiiba R; Itano J; Kimura G; Kawahara T; Tamura T; Kudo K; Kawamura T; Nakahara Y; Higo H; Himeji D; Takigawa N; Miyahara N;
PLoS One; 2024; 19(2):e0292507. PubMed ID: 38330061
[TBL] [Abstract][Full Text] [Related]
4. How to diagnose and treat a patient without human immunodeficiency virus infection having Pneumocystis jirovecii pneumonia?
Hänsel L; Schumacher J; Denis B; Hamane S; Cornely OA; Koehler P
Clin Microbiol Infect; 2023 Aug; 29(8):1015-1023. PubMed ID: 37086781
[TBL] [Abstract][Full Text] [Related]
5. Semiquantitative Real-Time PCR to Distinguish Pneumocystis Pneumonia from Colonization in a Heterogeneous Population of HIV-Negative Immunocompromised Patients.
Grønseth S; Rogne T; Hannula R; Åsvold BO; Afset JE; Damås JK
Microbiol Spectr; 2021 Sep; 9(1):e0002621. PubMed ID: 34346746
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of moderate-to-severe Pneumocystis pneumonia treated with adjunctive steroid in non-HIV-infected patients.
Moon SM; Kim T; Sung H; Kim MN; Kim SH; Choi SH; Jeong JY; Woo JH; Kim YS; Lee SO
Antimicrob Agents Chemother; 2011 Oct; 55(10):4613-8. PubMed ID: 21788460
[TBL] [Abstract][Full Text] [Related]
7. Outcome of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction in patients without human immunodeficiency virus infection.
Hardak E; Neuberger A; Yigla M; Berger G; Finkelstein R; Sprecher H; Oren I
Respirology; 2012 May; 17(4):681-6. PubMed ID: 22390188
[TBL] [Abstract][Full Text] [Related]
8. Pneumocystis carinii pneumonia in South African children infected with human immunodeficiency virus.
Zar HJ; Dechaboon A; Hanslo D; Apolles P; Magnus KG; Hussey G
Pediatr Infect Dis J; 2000 Jul; 19(7):603-7. PubMed ID: 10917216
[TBL] [Abstract][Full Text] [Related]
9. Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons.
McKinnell JA; Cannella AP; Kunz DF; Hook EW; Moser SA; Miller LG; Baddley JW; Pappas PG
Transpl Infect Dis; 2012 Oct; 14(5):510-8. PubMed ID: 22548840
[TBL] [Abstract][Full Text] [Related]
10. Blood urea nitrogen-to-serum albumin ratio and A-DROP are useful in assessing the severity of Pneumocystis pneumonia in patients without human immunodeficiency virus infection.
Akahane J; Ushiki A; Kosaka M; Ikuyama Y; Matsuo A; Hachiya T; Yoshiike F; Koyama S; Hanaoka M
J Infect Chemother; 2021 May; 27(5):707-714. PubMed ID: 33376033
[TBL] [Abstract][Full Text] [Related]
11. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients.
Roblot F; Godet C; Le Moal G; Garo B; Faouzi Souala M; Dary M; De Gentile L; Gandji JA; Guimard Y; Lacroix C; Roblot P; Becq-Giraudon B
Eur J Clin Microbiol Infect Dis; 2002 Jul; 21(7):523-31. PubMed ID: 12172743
[TBL] [Abstract][Full Text] [Related]
12. Clinical Manifestations and Prognostic Factors of Pneumocystis jirovecii Pneumonia without HIV.
Asai N; Motojima S; Ohkuni Y; Matsunuma R; Iwasaki T; Nakashima K; Sogawa K; Nakashita T; Kaneko N
Chemotherapy; 2017; 62(6):343-349. PubMed ID: 28719897
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of positive
Lee HY; Kang HS; Lee HY; Rhee CK; Lee SY; Kim SC; Kim SJ; Park YJ; Kim YK; Kang JY
Korean J Intern Med; 2017 May; 32(3):478-485. PubMed ID: 27951623
[TBL] [Abstract][Full Text] [Related]
14. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
15. Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies.
Tasaka S; Tokuda H
J Infect Chemother; 2012 Dec; 18(6):793-806. PubMed ID: 22864454
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Differences in Pneumocystis Pneumonia Infection Between HIV and Non-HIV Patients.
Nasr M; Mohammad A; Hor M; Baradeiya AM; Qasim H
Cureus; 2022 Aug; 14(8):e27727. PubMed ID: 36106266
[No Abstract] [Full Text] [Related]
17. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years.
Schmidt JJ; Lueck C; Ziesing S; Stoll M; Haller H; Gottlieb J; Eder M; Welte T; Hoeper MM; Scherag A; David S
Crit Care; 2018 Nov; 22(1):307. PubMed ID: 30454031
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
Kato H; Samukawa S; Takahashi H; Nakajima H
J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
[TBL] [Abstract][Full Text] [Related]
19. [Role of glucocorticoids in pneumocystis pneumonia in patients with non-HIV infection/AIDS (HIV/AIDS) and related mechanisms].
Guo YW; Li HC
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1249-1253. PubMed ID: 38044054
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and Prognostic Factors of Non-HIV Immunocompromised Patients With Pneumocystis Pneumonia Diagnosed by Metagenomics Next-Generation Sequencing.
Duan J; Gao J; Liu Q; Sun M; Liu Y; Tan Y; Xing L
Front Med (Lausanne); 2022; 9():812698. PubMed ID: 35308503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
